The Lancet2h
Software-based quantitative assessment of ablation margins: a new standard for liver tumour ablation
For a long time, thermal ablation was considered an alternative to surgical resection for patients with malignant liver tumours. However, it should now be regarded as the preferred treatment for ...
The Lancet2h
Preventing vertical transmission of HBV in LMICs: what could HBcrAg rapid tests add?
Hepatitis B virus (HBV) is the leading cause of cirrhosis, hepatocellular carcinoma, and liver-related death globally.1,2 The highest prevalence is found in low-income and middle-income countries ...
The Lancet1d
An overview of influenza H5 vaccines
Pandemic influenza remains a significant global health threat, as signalled by the circulation and cross-species transmission of avian influenza A(H5N1) viruses from the clade 2.3.4.4b, including ...
The Lancet1d
A turning point for global health: challenge or opportunity?
Investments in programmes such as the US President's Emergency Plan for AIDS Relief (PEPFAR), the Global Fund to Fight AIDS, ...
The Lancet1d
Prevention and control of HPV-related cancers in people living with HIV
The advent of effective antiretroviral therapy (ART) has increased the lifespan of many people living with HIV. As a result, ...
The Lancet2d
Placebo responses in clinical trials of refractory chronic cough: mechanisms, challenges, and mitigation strategies
Refractory chronic cough is a cough that persists for over 8 weeks and does not respond to treatment of any underlying cause. Recent randomised trials for refractory chronic cough have shown ...
The Lancet2d
Long-acting PrEP for adolescent girls and young women
Nearly half (44%) of all new HIV infections globally in 2023 were in women and girls.1 Adolescent girls and young women are disproportionately affected by HIV, particularly in sub-Saharan Africa where ...
The Lancet1d
Safeguarding patient and provider rights in an era of US anti-immigration policies
Like political leaders throughout Europe, US President Donald Trump pledged if elected to detain and deport millions of migrants without legal documentation or with temporary protected status.1 Since ...
The Lancet2d
The potential for annual long-acting HIV pre-exposure prophylaxis
Pre-exposure prophylaxis (PrEP) is the advent of antiretroviral treatment use for people at increased risk of acquiring HIV-1 ...
The Lancet7d
Global and regional causes of maternal deaths 2009–20: a WHO systematic analysis
Haemorrhage remains the leading cause of death, despite the existence of effective clinical interventions, emphasising the ...
The Lancet2d
Another step towards defeating meningitis
Since the introduction of the MenA conjugate vaccine in the African meningitis belt through mass vaccination campaigns and its inclusion in the Essential Program on Immunization (EPI), cases of ...
The Lancet2d
Effect of digital adherence technologies on treatment outcomes in people with drug-susceptible tuberculosis: four pragmatic, cluster-randomised trials
Digital adherence technologies did not reduce poor treatment outcomes in the four countries investigated. The use of digital adherence technologies should be based on careful review of additional data ...